These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2881309)

  • 21. Role of prolactin in lactation-induced changes in brown adipose tissue.
    Chan E; Swaminathan R
    Am J Physiol; 1990 Jan; 258(1 Pt 2):R51-6. PubMed ID: 2301647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats.
    Fuller RW; Snoddy HD; Molloy BB
    J Pharmacol Exp Ther; 1986 Nov; 239(2):454-9. PubMed ID: 2430093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Quipazine antagonizing baclofen activity. Influence of baclofen and gamma-hydroxybutyric acid on serotonin metabolism in rat brain (author's transl)].
    Waldmeier PC; Maître L
    Arzneimittelforschung; 1978; 28(9):1507-8. PubMed ID: 582544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of quipazine and LSD on monoamines in the rat striatum.
    Miśkiewicz M; Rokosz-Pelc A; Vetulani J
    Pol J Pharmacol Pharm; 1979; 31(5):489-92. PubMed ID: 94944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats.
    Lawson DM; Gala RR
    Endocrinology; 1978 Mar; 102(3):973-81. PubMed ID: 311279
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
    Nagahama S; Chen YF; Oparil S
    J Pharmacol Exp Ther; 1984 Feb; 228(2):370-5. PubMed ID: 6363675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced locomotor activity.
    Feigenbaum JJ; Yanai J; Klawans HL
    J Neural Transm; 1982; 54(3-4):145-51. PubMed ID: 7130970
    [No Abstract]   [Full Text] [Related]  

  • 29. Dopaminergic activity of quipazine.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of quipazine on pre- and postsynaptic serotonin receptors: single cell studies in the rat CNS.
    Blier P; de Montigny C
    Neuropharmacology; 1983 Apr; 22(4):495-9. PubMed ID: 6856049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral and biochemical correlates of chronic administration of quipazine.
    Valencia-Flores M; Campos-Sepulveda E; Galindo-Morales JA; Lujan M; Colotla VA
    Pharmacol Biochem Behav; 1990 Jun; 36(2):299-304. PubMed ID: 2356204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity of serotoninergic involvement in the decrease of food intake induced by quipazine in the rat.
    Samanin R; Bendotti C; Candelaresi G; Garattini S
    Life Sci; 1977 Nov; 21(9):1259-66. PubMed ID: 270605
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of endophyte-infected fescue on concentrations of prolactin in blood sera and the anterior pituitary and concentrations of dopamine and dopamine metabolites in brains of steers.
    Schillo KK; Leshin LS; Boling JA; Gay N
    J Anim Sci; 1988 Mar; 66(3):713-8. PubMed ID: 3378927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further evidence that prolactin secretion in adult female rats is differently modified after neonatal estrogenization or androgenization: responses to methysergide, quipazine, and pizotifen.
    Collado D; Aguilar E
    Physiol Behav; 1993 Jan; 53(1):161-5. PubMed ID: 8434056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serum prolactin levels during sleep and in metoclopramide stimulation in normoprolactinemic anovulation and ovulation induction with bromocriptine].
    Suginami H; Ito T; Hamada K; Yano K; Matsuura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):728-34. PubMed ID: 3722953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
    Carlton J; Rowland N
    Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of the locus coeruleus in the potentiation of the quipazine-induced head-twitch response by diazepam and beta-adrenoceptor agonists.
    Handley SL; Singh L
    Neuropharmacology; 1986 Dec; 25(12):1315-21. PubMed ID: 2882436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further evidence that serotonin is a neurotransmitter involved in the control of prolactin secretion.
    Clemens JA; Sawyer BD; Cerimele B
    Endocrinology; 1977 Mar; 100(3):692-8. PubMed ID: 401022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced increases in locomotor activity.
    Feigenbaum JJ; Yanai J; Klawans HL
    J Neural Transm; 1983; 57(1-2):27-37. PubMed ID: 6619829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased plasma prolactin levels induced in rats by d-fenfluramine: relation to central serotonergic stimulation.
    Quattrone A; Di Renzo G; Schettini G; Tedeschi G; Scopacasa F
    Eur J Pharmacol; 1978 May; 49(2):163-7. PubMed ID: 149011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.